Abstract
The use of reverse genetics to generate recombinant viruses allows the researcher to investigate the exact functional significance of particular viral genes during the virus life cycle, by means of their deletion or modification in the viral genome. These studies can extend to the introduction of viral or foreign genetic material into ectopic sites in the viral genome, to investigate viral cis-control sequences or to phenotypically modify or tag the recombinant virus. Genetically modified viruses may also have applications in biotechnology and gene therapy. Such studies are well advanced for herpes simplex virus (HSV), a relative of human cytomegalovirus (HCMV), but have been relatively limited for HCMV itself.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Spaete, R. R. and Mocarski, E. S. (1987) Insertion and deletion mutagenesis of the human cytomegalovirus genome. Proc. Natl. Acad. Sci. USA 84, 7213–7217.
Jones, T. R., Muzithras, V. P., and Gluzman, Y. (1991) Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential. J. Virol. 65, 5860–5872.
Jones, T. R. and Muzithras, V. P. (1992) A cluster of dispensable genes within the human cytomegalovirus genome short component: IRS1, US1 through US5, and the US6 family. J. Virol. 66, 2541–2546.
Browne, H., Churcher, M., and Minson, T. (1992) Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted. J. Virol. 66, 6784–6787.
Kaye, J., Browne, H., Stoffel, M., and Minson, T. (1992) The UL16 gene of human cytomegalovirus encodes a glycoprotein that is dispensable for growth in vitro. J. Virol. 66, 6606–6615.
Kohler, C. P., Kerry, J. A., Carter, M., Muzithras, V. P., Jones, T. R., and Stenberg, R. M. (1994) Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J. Virol. 68, 6589–6597.
Kemble, G., Duke, G., Winter, R., and Spaete, R. (1996) Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids. J. Virol. 70, 2044–2048.
Wolff, D., Jahn, G., and Plachter, B. (1993) Generation and effective enrichment of selectable human cytomegalovirus mutants using site-directed insertion of the neo gene. Gene 130, 167–173.
Schmolke, S., Kern, H. F., Drescher, P., Jahn, G., and Plachter, B. (1995) The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69, 5959–5968.
Greaves, R. F., Brown, J. M., Vieira, J., and Mocarski, E. S. (1995) Selectable insertion and deletion mutagenesis of the human cytome-galovirus genome using the Escherichia coli guanosine phosphoribosyl transferase (gpt) gene. J. Gen. Virol. 76, 2151–2160.
Prichard, M. N., Duke, G. M., and Mocarski, E. S. (1996) Human cytomegalovirus uracil DNA glycosylase is required for the normal temporal regulation of both DNA synthesis and viral replication. J. Virol. 70, 3018–3025.
Greaves, R. F. and Mocarski, E. S. (1998) Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J. Virol. 72, 366–379.
Vieira, J., Schall, T. J., Corey, L., and Geballe, A. P. (1998) Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J. Virol. 72, 8158–8165.
Messerle, M., Crnkovic, I., Hammerschmidt, W., Ziegler, H., and Kosinowski, U. H. (1997) Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. USA 94, 14759–14763.
Morgenstern, J. P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18, 3587–3596.
Thomsen, D. R. and Stinski, M. F. (1981) Cloning of the human cytomegalovirus genome as endonuclease XbaI fragments. Gene 16, 207–216.
Fleckenstein, B., Muller, I., and Collins, J. (1982) Cloning of the complete human cytomegalovirus genome in cosmids. Gene 18, 39–46.
Oram, J. D., Downing, R. G., Akrigg, A., Dollery, A. A., Duggleby, C. J., Wilkinson, G. W., and Greenaway, P. J. (1982) Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J. Gen. Virol. 59, 111–129.
Chee, M. S., Bankier, A. T., Beck, S., Bohni, R., Brown, C. M., Cerny, R., Horsnell, T., Hutchison, C. A. I., Kouzarides, T., Martignetti, J. A., Preddie, E., Satchwell, S. C., Tomlinson, P., Weston, K. M., and Barrell, B. G. (1990) Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154, 125–170.
Paulus, W., Baur, I., Boyce, F. M., Breakefield, X. O., and Reeves, S. A. (1996) Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J. Virol. 70, 62–67.
Halbert, C. L., Demers, G. W., and Galloway, D. A. (1991) The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65, 473–478.
Compton, T. (1993) An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67, 3644–3648.
Chen, C. A. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745–2752.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Greaves, R.F. (2000). Construction of Recombinant Human Cytomegalovirus. In: Sinclair, J. (eds) Cytomegalovirus Protocols. Methods in Molecular Medicine™, vol 33. Humana Press. https://doi.org/10.1385/1-59259-244-9:153
Download citation
DOI: https://doi.org/10.1385/1-59259-244-9:153
Publisher Name: Humana Press
Print ISBN: 978-0-89603-749-6
Online ISBN: 978-1-59259-244-9
eBook Packages: Springer Protocols